Attached files

file filename
EX-5.1 - EX-5.1 - Verastem, Inc.a11-28014_7ex5d1.htm
EX-23.2 - EX-23.2 - Verastem, Inc.a11-28014_7ex23d2.htm

 

As filed with the Securities and Exchange Commission on January 26, 2012

Registration No. 333-                        

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


 

FORM S-1

 

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933


 

Verastem, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

2834

(Primary Standard Industrial

Classification Code Number)

 

27-3269467

(I.R.S. Employer

Identification Number)

 

215 First Street, Suite 440
Cambridge, MA 02142
(617) 252-9300

 

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)


 

Christoph Westphal, M.D., Ph.D.
President and Chief Executive Officer
Verastem, Inc.
215 First Street, Suite 440
Cambridge, Massachusetts 02142
(617) 252-9300

(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)


 

copies to:

 

David E. Redlick, Esq.
Brian A. Johnson, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street
Boston, Massachusetts 02109
(617) 526-6000

 

Patrick O’Brien, Esq.
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, Massachusetts 02199
(617) 951-7000

 


 

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. o

 

If this Form is filed to register additional securities for an offering pursuant Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x 333-177677

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

 

Large accelerated filer o

Accelerated filer o

Non-accelerated filer x (Do not check if a smaller reporting company)

Smaller reporting company o

 


 

CALCULATION OF REGISTRATION FEE

 

 

Proposed maximum

 

 

Title of each class of securities
to be registered

 

aggregate
offering price (1)

 

Amount of
registration fee(2)

Common Stock, $0.0001 par value per share

 

$6,325,000

 

$725

(1) Estimated solely for the purpose of calculating a registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.

(2) Calculated pursuant to  Rule 457(o) based on an estimate of the proposed maximum aggregate offering price.

 

This Registration Statement shall become effective upon filing with the Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.

 

 

 



 

Explanatory Note and Incorporation By Reference

 

This registration statement is being filed with respect to the registration of additional shares of common stock, par value $0.0001 per share, of  Verastem, Inc., a Delaware corporation, pursuant to Rule 462(b) under the Securities Act of 1933, as amended.  The contents of the earlier registration statement on Form S-1 (File No. 333-177677), which was declared effective by the Commission on January 26, 2012, are incorporated in this registration statement by reference.

 

The required opinions and consents are listed on an Exhibit Index attached hereto and filed herewith.

 



 

Signatures

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 26th day of January, 2012.

 

 

VERASTEM, INC.

 

 

 

 

 

 

By:

/s/ Christoph Westphal, M.D., Ph.D.

 

 

 

  Name: Christoph Westphal, M.D., Ph.D.

 

 

  Title: President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

Title

 

Date

 

 

 

 

/s/ Christoph Westphal, M.D., Ph.D.

President, Chief Executive Officer and Director

 

January 26, 2012

Christoph Westphal, M.D., Ph.D.

(Principal executive officer)

 

 

 

 

 

 

/s/ Robert Forrester

Chief Operating Officer

 

January 26, 2012

Robert Forrester

(Principal financial and accounting officer)

 

 

 

 

 

 

*

Director

 

January 26, 2012

Richard Aldrich

 

 

 

 

 

 

 

*

Director

 

January 26, 2012

John K. Clarke

 

 

 

 

 

 

 

*

Director

 

January 26, 2012

Ansbert Gadicke, M.D.

 

 

 

 

 

 

 

*

Director

 

January 26, 2012

Stephen Kraus

 

 

 

 

 

 

 

*

Director

 

January 26, 2012

Henri Termeer

 

 

 

 

 

 

 

 

 

 

 

*By:

 

 

 

 

 

/s/ Christoph Westphal, M.D., Ph.D.

 

 

 

 

Christoph Westphal, M.D., Ph.D.

 

 

 

 

Attorney-in-Fact

 

 

 

 



 

Exhibit Index

 

Exhibit No.

 

Description

 

 

 

5.1

 

 

Opinion of Wilmer Cutler Pickering Hale and Dorr LLP

23.1

 

 

Consent of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit 5.1)

23.2

 

 

Consent of Ernst & Young LLP

24.1

*

 

Powers of Attorney (included on signature page)

 


* Filed as Exhibit 24.1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-177677) filed with the Commission on November 3, 2011, as amended, and incorporated in this registration statement by reference.